Biomedica Italia has signed an agreement with the German company Cybion GmbH for the distribution of the Tibial Transversal Transport System.
The TTT system is designed to improve the treatment of diabetic foot ulcer and peripheral vascular conditions. 

With this new treatment you could avoid lower limb amputations in Patients suffering from DFU.

Inspired by Ilizarov’s tension-stress principle, the transversal transport of the bone fragment generates the following effects:

• Reconstruction of the microvascular network (Neo-Vasculature)1

• Gradual increase in blood supply to the whole limb

• Improved circulation in the distal leg and foot

After more than 3 years and more than 1,200 documented cases in clinical research, the TTT system has proven to be an effective treatment to resolve a wide range of ischemic diseases of the lower limbs, especially offering a simple treatment for the management of patients with DFUs.

With this agreement, Biomedica Italia completes the offer of products dedicated to the care and treatment of the diabetic foot, confirming the interest in the search for innovative solutions and for improving the quality of care.

Go to the product.